Clinical Trials Directory

Trials / Conditions / Recurrent Ovarian High Grade Serous Adenocarcinoma

Recurrent Ovarian High Grade Serous Adenocarcinoma

7 registered clinical trials studyying Recurrent Ovarian High Grade Serous Adenocarcinoma — 4 currently recruiting.

StatusTrialSponsorPhase
WithdrawnTesting the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without B
NCT06393751
National Cancer Institute (NCI)Phase 1 / Phase 2
RecruitingTesting Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovaria
NCT05950464
National Cancer Institute (NCI)Phase 1
RecruitingVaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity
NCT05920798
Mayo ClinicPhase 1 / Phase 2
WithdrawnComparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent
NCT05295589
National Cancer Institute (NCI)Phase 2
RecruitingIACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
NCT05039801
M.D. Anderson Cancer CenterPhase 1
RecruitingTesting the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
NCT04633239
National Cancer Institute (NCI)Phase 1
Active Not RecruitingComparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents
NCT04739800
National Cancer Institute (NCI)Phase 2